Eugene David<br>...The One-Minute Pundit

Posted 9:36 AM by Gene

“We generally expected that when the Democrats regained control of Congress, that they would closely scrutinize some of the industries that they believed had been particularly favored by the Republicans and unreasonably benefited in certain ways,” said Bret Koplow, a pharmaceutical industry lobbyist at Patton Boggs.

“There was the perception that certain industries, including pharmaceuticals, were getting away with a lot,” he said.

OOPS!

“I don’t fault my former colleagues for looking into these cases. I’d be looking at them, too, if I was chairman, because they are such highly publicized cases,” said former Rep. Billy Tauzin (R-La.), who in 2004 stepped down as chairman of the House Commerce Committee to head the Pharmaceutical Research and Manufacturers of America.

“We are not only anxious but anxious and willing to make some changes to these real or perceived problems.”

DOUBLE OOPS!

And the pressure is not just coming from Democrats.

The House Commerce Committee has had bipartisan cooperation in its investigations.

And in the Senate Finance Committee, the ranking Republican, Sen. Chuck Grassley of Iowa, has been leading the charge, continuing investigations that began when he was chairman.

TRIPLE OOPS!!!!!

[Emphasis added]